Schwielowsee, Germany

Barbara Baude

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Barbara Baude - Innovator in Core-Shell Particle Technology

Introduction

Barbara Baude is a prominent inventor based in Schwielowsee, Germany. She has made significant contributions to the field of materials science, particularly in the development of core-shell (CS) particles and microcapsules. Her innovative approach has led to advancements in various applications, including drug delivery systems.

Latest Patents

Barbara Baude holds a patent for a method of producing core-shell particles and microcapsules using porous templates. The patent describes a process where at least one active compound is adsorbed in porous templates, resulting in templates filled with active compounds. The process involves applying a primer layer to facilitate the construction of the capsule shell, which is formed by applying alternately charged polyelectrolyte layers. The filled CS particles are obtained, and by dissolving the templates, the active compounds are released into the interior of the microcapsules. This innovative method allows for the active compounds to remain enclosed or be slowly released from the capsule.

Career Highlights

Barbara Baude is associated with Capsulution Pharma AG, where she continues to work on her innovative projects. Her expertise in the field has positioned her as a key player in the development of advanced microencapsulation technologies.

Collaborations

Some of her notable coworkers include Lars Siegfried Dahne and Lars Dähne, who have collaborated with her on various projects related to her patented technologies.

Conclusion

Barbara Baude's contributions to the field of core-shell particle technology exemplify her innovative spirit and dedication to advancing materials science. Her work continues to influence the development of new applications in drug delivery and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…